• Aucun résultat trouvé

[PDF] Top 20 Validation of a chemiluminescent assay for specific SARS-CoV-2 antibody

Has 10000 "Validation of a chemiluminescent assay for specific SARS-CoV-2 antibody" found on our website. Below are the top 20 most common "Validation of a chemiluminescent assay for specific SARS-CoV-2 antibody".

Validation of a chemiluminescent assay for specific SARS-CoV-2 antibody

Validation of a chemiluminescent assay for specific SARS-CoV-2 antibody

... al.: Validation of a chemiluminescent assay for specific SARS-CoV-2 antibody The validation of SARS-CoV-2 ... Voir le document complet

9

Deciphering SARS-CoV-2 Virologic and Immunologic Features

Deciphering SARS-CoV-2 Virologic and Immunologic Features

... aspect of antibody-based therapy could be the use of recombinant antibody targeting spike protein of ...target SARS-CoV-2 S. CR3022, which was initially isolated ... Voir le document complet

41

High clinical performance and quantitative assessment of antibody kinetics using a dual recognition assay for the detection of SARS-CoV-2 IgM and IgG antibodies

High clinical performance and quantitative assessment of antibody kinetics using a dual recognition assay for the detection of SARS-CoV-2 IgM and IgG antibodies

... is a useful strategy for the diagnosis, the char- acterization of the course of the disease, for identifying convalescent plasma donors as well as for epidemiological study, ... Voir le document complet

6

Analytical and clinical validation of an ELISA for specific SARS-CoV-2 IgG, IgA and IgM antibodies

Analytical and clinical validation of an ELISA for specific SARS-CoV-2 IgG, IgA and IgM antibodies

... Assessment of the clinical specificity Seventy ‐nine samples were tested to assess the ...positive for the following viral, bacterial and infection from parasite origin were included to assess the possible ... Voir le document complet

10

Challenges and Issues of Anti-SARS-CoV-2 Vaccines

Challenges and Issues of Anti-SARS-CoV-2 Vaccines

... kept for all risk groups, this includes low, moderate and high risk groups [who obviously should be given priority ( 39 )] but should be distributed to the highest number of people in order to slow down or ... Voir le document complet

12

Conséquences neurologiques de l'infection au SARS- CoV-2 : Analyse bibliographique

Conséquences neurologiques de l'infection au SARS- CoV-2 : Analyse bibliographique

... - 13 - et permettent d’imaginer que l’infection au SAR-CoV-2 déclenche les mêmes processus neuro-inflammatoires. De plus, ces perturbations inflammatoires de l’homéostasie cérébrale sont connues pour avoir ... Voir le document complet

30

Implications neurologiques de l’infection à SARS-CoV-2 | Louvain Médical

Implications neurologiques de l’infection à SARS-CoV-2 | Louvain Médical

... implications of SARS-CoV-2 infection A steadily increasing number of cases with neurological manifestations that are potentially related to COVID-19 are being reported in the ... Voir le document complet

3

Tracing the origins of SARS-COV-2 in coronavirus phylogenies: a review

Tracing the origins of SARS-COV-2 in coronavirus phylogenies: a review

... role of pangolin viruses in this process remains uncertain because, although the possible importance of the RBD identified in the CoV from pangolin is estab- lished, the region of strong ... Voir le document complet

18

Evolution of viral quasispecies during SARS-CoV-2 infection

Evolution of viral quasispecies during SARS-CoV-2 infection

... Supplementary Table 1: Experimental conditions for the amplification of the 2 fragments including the Spike, Envelope, Membrane and Nucleocapsid genes. Volume (µl) Final concentration PCR program ... Voir le document complet

36

Sensitive visualization of SARS-CoV-2 RNA with CoronaFISH

Sensitive visualization of SARS-CoV-2 RNA with CoronaFISH

... yielded a mean of only 0.5 +/- 0.3 gold particles/μm 2 in nuclear and cytoplasmic areas (n=9 regions, for a total of ...μm 2 ), indicative of low background ... Voir le document complet

26

Estimating the burden of SARS-CoV-2 in France

Estimating the burden of SARS-CoV-2 in France

... models for the epidemic to ICU admission and bed occupancy (Figure 3A-B, Figure S5, Tables ...implementation of the lockdown was 3.31 (95% CrI: 3.18-3.43). At a national level, the lockdown resulted ... Voir le document complet

44

Chaos game representation dataset of SARS-CoV-2 genome

Chaos game representation dataset of SARS-CoV-2 genome

... Chaos game representation dataset of SARS-CoV-2 genome The MIT Faculty has made this article openly available. Please share how this access benefits you. Your story matters. Citation Barbosa, ... Voir le document complet

6

New Chemical Modalities Enabling Specific RNA Targeting and Degradation: Application to SARS-CoV-2 RNA

New Chemical Modalities Enabling Specific RNA Targeting and Degradation: Application to SARS-CoV-2 RNA

... the SARS-CoV-2 frameshifting element RNA that bears a 1x1 nucleotide UU internal loop in its stem important for frameshifting element ...detail for their affinity and selectivity ... Voir le document complet

5

View of Pericardial effusion: an underrated complication of SARS-CoV-2

View of Pericardial effusion: an underrated complication of SARS-CoV-2

... d’admission a mis en évidence des images classiques d’une atteinte par SARS-CoV-2 en verre dépoli mais également un épanchement péricardique de 16 ... Voir le document complet

4

View of SARS-CoV-2 in Pediatric Intensive Care Unit

View of SARS-CoV-2 in Pediatric Intensive Care Unit

... famille a été autorisée moyennant un port de masque ...et a certainement été bénéfique pour la prise en charge des enfants hospitalisés en ...à SARS-CoV-2 a pu être discuté de la ... Voir le document complet

16

PTSD as the second tsunami of the SARS-Cov-2 pandemic

PTSD as the second tsunami of the SARS-Cov-2 pandemic

... Conflict of interest. The authors of this work declare no conflict of ...reintegration of soldiers with chronic PTSD: A new approach integrating psychological resources and values in ... Voir le document complet

3

SARS-CoV-2 viral dynamics in non-human primates

SARS-CoV-2 viral dynamics in non-human primates

... coronavirus 2 (SARS-CoV-2) which originated in Wuhan, China, at the end of December 2019, has spread rapidly around the world, resulting at the end of December 2020 in more than ... Voir le document complet

16

L’ARN polymérase   COVID-19 - Le talon d’Achille du SARS-CoV-2

L’ARN polymérase   COVID-19 - Le talon d’Achille du SARS-CoV-2

... Je me suis tout d’abord installé à Luminy en 1998 pour travailler sur les enzymes de la réplication, en particulier chez le virus de la dengue. Avec ma première étudiante qui effectuait une thèse de doctorat, nous avions ... Voir le document complet

5

Tracing the origins of SARS-CoV-2 in coronavirus phylogenies

Tracing the origins of SARS-CoV-2 in coronavirus phylogenies

... viruses of low public health significance, as they were mainly responsible for benign diseases such as seasonal ...emergence of SARS-CoV in 2002, studies conducted in the United States ... Voir le document complet

33

Immunité adaptative contre le virus SARS-CoV-2

Immunité adaptative contre le virus SARS-CoV-2

... le SARS-CoV-2 pourrait affecter la qualité et la durabilité de la réponse ...immunitaires a un impact majeur sur la progression de la maladie [13] ...le SARS-CoV-2 ... Voir le document complet

7

Show all 10000 documents...